• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>AtheroGenics

AtheroGenics

  1. All
  2. 3rd Party
  3. Investing
  1. Stealth BioTherapeutics Announces the Appointment of Mark P. Colonnese as Chief Financial Officer

    Stealth BioTherapeutics Announces the Appointment of Mark P. Colonnese as Chief Financial Officer

  2. Five Stocks That Look Completely Worthless

    We see zero value in these near-bankrupt businesses.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.